Vercellini Paolo
No ORCID on file
· 3 papers in corpus
· active 1994-2018
Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…